Company intelligence / Profile preview

PSG Consulting

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Pharmaceutical Strategies Group (PSG) is a leading pharmacy intelligence and technology-enabled solutions firm that provides strategic consulting to health plans, employers, and health systems. The company specializes in optimizing pharmacy benefit programs, managing drug spend, and providing 340B program oversight. PSG leverages proprietary data analytics platforms, such as Artemis, to deliver actionable insights into drug trends and clinical performance. In late 2023, the firm was acquired by Mercer, a business of Marsh McLennan, to enhance their pharmacy benefit management capabilities. Headquartered in Plano, Texas, PSG is recognized for its independent, data-driven approach to reducing costs and improving health outcomes for its clients.

Industry: Consulting

Beyond the preview

Go deeper on PSG Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSG Consulting.

Explore the full profile